Affymetrix, Inc. (NASDAQ: AFFX) today announced the launch of the
GeneAtlas™ System, a complete, personal solution for processing
Affymetrix arrays and characterizing changes in gene expression in a
variety of research applications.
“We see opportunities to develop the microarray gene expression market
by making it more accessible to new users”
By combining Affymetrix’ market-leading gene expression technology with
the simplest workflow available and an unprecedented price, the
GeneAtlas System extends the power of whole-genome microarray analysis
to researchers who are constrained by budget or intimidated by the
complexity of microarray systems.
"The GeneAtlas System gives life science researchers like me an
independence we did not have before,” said Steve White, PhD, technical
director of the Professional Science Master of Biotechnology Program at
San Jose State University and one of the first scientists to use the
GeneAtlas System. “It took us less than two hours to install and
required no tools or engineers to help. That speed and ease of use
continues with experiments, which can be initiated in less than five
minutes. On top of that, the size of the system enables my scientists to
do their work even in our small lab."
The system, which is available immediately, includes all required
instrumentation, training materials, and easy-to-use data analysis
programs that provide biologically relevant results. It’s designed to
meet the needs of researchers with no microarray experience, as well as
low- to medium-throughput service laboratories, educational
laboratories, and emerging markets.
“We see opportunities to develop the microarray gene expression market
by making it more accessible to new users,” said Greg Fisher, associate
director of product marketing, systems and software, at Affymetrix. “We
have bundled everything a researcher needs in one complete, affordable
system.”
The GeneAtlas System utilizes a convenient new array strip format that
enables researchers to interrogate four distinct samples simultaneously.
Array strips are now available in options that provide comprehensive
coverage of the transcribed human, mouse, or rat genomes for expression
profiling. The array strip is also available for custom array designs
through the MyGeneChip™ Custom Array Program. Additional arrays and
applications will be introduced in the future.
“The GeneAtlas System eliminates workflow, data analysis, and cost
barriers to performing whole-genome analysis,” said Kevin King,
president and CEO of Affymetrix. “Affymetrix is providing a new
generation of life science researchers with a system that offers
uncompromised performance.”